CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
Nike FuelBand (NFB)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01822457
NCT01822457N/ACompleted

Effect of Nike FuelBand on Exercise and Function in Claudicants; a Randomised Controlled Trial

Imperial College London·interventional·Posted Apr 2, 2013·Updated Feb 17, 2020

In Brief

A clinical study evaluating Nike FuelBand (NFB) for Peripheral Vascular Disease and Intermittent Claudication. Completed, enrolled 37 participants across 1 site.

Detailed Summary

This is a randomised controlled study of patients suffering from intermittent claudication (IC), to assess the impact of wearing a Nike FuelBand (NFB) on walking distances, exercise levels and quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 2, 2013
Enrollment StartAug 1, 2013
Primary CompletionDec 1, 2015
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.3 years ago

Interventions

Nike FuelBand (NFB)device

The Nike Fuel Band (NFB) is a wrist-worn sensor with a built-in accelerometer for motion quantification. It is programmed to estimate the number of steps taken per day, and also predict energy expenditure in units known as Nike Fuel. Accompanying software allows the user to set daily targets and monitor their activity through a graphical user interface.